Document Detail

Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.
MedLine Citation:
PMID:  10853217     Owner:  NLM     Status:  MEDLINE    
A patient with perforated appendicitis developed progressive vasodilatory shock which was complicated by perioperative acute myocardial infarction. Cardiovascular support included dopamine infusion, and later, intra-aortic balloon counterpulsation balloon pump and noradrenaline and dobutamine infusion. Vasopressin was introduced as a final attempt to reverse the refractory shock and was associated with recovery. The experience with this case suggests that vasopressin may be a valuable adjunct to the treatment of catecholamine-resistant vasodilatory shock.
T W Lim; S Lee; K S NG
Related Documents :
19332967 - Escherichia coli septic shock masquerading as st-segment elevation myocardial infarction.
8917277 - Direct current shocks to the heart generate free radicals: an electron paramagnetic res...
9727657 - Effect of ventricular shock strength on cardiac hemodynamics.
4061257 - Right ventricular infarction with shock but without significant left ventricular infarc...
20661337 - Comparison of left ventricular hypertrophy, fibrosis and dysfunction according to vario...
24424157 - Remote ischaemic conditioning and ischaemic heart disease.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Anaesthesia and intensive care     Volume:  28     ISSN:  0310-057X     ISO Abbreviation:  Anaesth Intensive Care     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-10-06     Completed Date:  2000-10-06     Revised Date:  2006-08-28    
Medline Journal Info:
Nlm Unique ID:  0342017     Medline TA:  Anaesth Intensive Care     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  313-7     Citation Subset:  IM    
Department of Anaesthesia and Surgical Intensive Care, Changi General Hospital, Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic alpha-Agonists / administration & dosage,  therapeutic use
Adrenergic beta-Agonists / administration & dosage,  therapeutic use
Appendicitis / complications
Cardiotonic Agents / therapeutic use
Dobutamine / administration & dosage,  therapeutic use
Dopamine / therapeutic use
Infusions, Intravenous
Intestinal Perforation / complications
Intra-Aortic Balloon Pumping
Intraoperative Complications
Myocardial Infarction / complications
Norepinephrine / administration & dosage,  therapeutic use
Recovery of Function
Shock / drug therapy*,  etiology
Vasoconstrictor Agents / therapeutic use*
Vasodilation / drug effects
Vasopressins / therapeutic use*
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Adrenergic beta-Agonists; 0/Cardiotonic Agents; 0/Vasoconstrictor Agents; 11000-17-2/Vasopressins; 34368-04-2/Dobutamine; 51-41-2/Norepinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pethidine reverses morphine-induced delirium.
Next Document:  Target-controlled intravenous anaesthesia with bispectral index monitoring for thoracotomy in a pati...